Abstract: Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, induce the expression of a wide variety of genes, including intercellular adhesion molecule-1 (ICAM-1). Ursolic acid (3β-hydroxy-urs-12-en-28-oic acid) was identified to inhibit the cell-surface ICAM-1 expression induced by pro-inflammatory cytokines in human lung carcinoma A549 cells. Ursolic acid was found to inhibit the TNF-α-induced ICAM-1 protein expression almost completely, whereas the TNF-α-induced ICAM-1 mRNA expression and NF-κB signaling pathway were decreased only partially by ursolic acid. In line with these findings, ursolic acid prevented cellular protein synthesis as well as amino acid uptake, but did not obviously affect nucleoside uptake and the subsequent DNA/RNA
syntheses. This inhibitory profile of ursolic acid was similar to that of the Na + /K + -ATPase inhibitor, ouabain, but not the translation inhibitor, cycloheximide. Consistent with this notion, ursolic acid was found to inhibit the catalytic activity of Na + /K + -ATPase. Thus, our present study reveals a novel molecular mechanism in which ursolic acid inhibits Na + /K + -ATPase activity and prevents the TNF-α-induced gene expression by blocking amino acid transport and cellular protein synthesis.
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Introduction
Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, induce the expression of a variety of genes essential for inflammatory responses, including intercellular adhesion molecule-1 (ICAM-1; CD54) [1] . In response to pro-inflammatory cytokines, ICAM-1 expression is induced on the surface of vascular endothelial cells and required for tissue infiltration of circulating leukocytes [2] . Thus, ICAM-1 plays a critical role in inflammatory response and its expression and function are regarded as a potential target of therapeutic intervention. ICAM-1 expression is regulated mainly at the transcription level and induced by the transcription factor nuclear factor κB (NF-κB) [3] .
The NF-κB signaling pathway is induced by various stimuli, including pro-inflammatory cytokines, infectious agents, and chemical/physical stress. The NF-κB dimer is sequestered in the cytosol by associating with the inhibitor of NF-κB (IκB) family of proteins [4] . Upon TNF-α stimulation, TNF receptor 1 triggers the activation of IB kinase and phosphorylated IκB undergoes ubiquitination and subsequent hydrolysis by the proteasome [5] . The NF-κB dimer then translocates from the cytosol to the nucleus where it activates the transcription of responsive genes that regulate inflammation, proliferation, cell death, cell survival, and angiogenesis [6] . Many types of natural and synthetic small molecules have been reported to block the NF-κB signaling pathway and its downstream gene expression [7] .
Ursolic acid (3β-hydroxy-urs-12-en-28-oic acid) ( Figure 1 ) is a natural pentacyclic triterpenoid that is often found as a major component of medicinal herbs, foods, and other plants. It has been reported that ursolic acid possesses a wide range of biological activities, such as anti-inflammatory and anti-carcinogenic activities [8] . In a screening for anti-inflammatory agents, we were able to isolate and investigate many plant-derived natural compounds. We found that ursolic acid most effectively inhibits the inducible expression of cell-surface ICAM-1 among ursane-, oleanane-, lupane-, and taraxasterane-type triterpenes purified from Nerium oleander [9, 10] . In relation to this finding, it has been thus far reported that ursolic acid inhibits the NF-κB-dependent signaling pathway and gene expression [11] [12] [13] [14] [15] [16] [17] [18] . However, in contrast to these reports, we unexpectedly found that ursolic acid inhibits ICAM-1 expression more effectively by targeting intracellular processes downstream of mRNA expression. In this study, the molecular mechanism by which ursolic acid inhibits ICAM-1 expression was investigated. 
Experimental Section

Cell Culture
Human lung carcinoma A549 cells (JCRB0076) and human fibrosarcoma HT-1080 cells (JCRB9113) were provided by Health Science Research Resources Bank (Osaka, Japan). A549 cells, HT-1080 cells and human breast adenocarcinoma MCF7 cells were maintained in RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% (v/v) heat-inactivated fetal calf serum (JRH Biosciences, Lenexa, KS, USA) and penicillin-streptomycin mixed solution.
Reagents
Ursolic acid was prepared from the leaves of Nerium oleander as described previously [9] or commercially purchased from Sigma-Aldrich (St. Louis, MO, USA). Cycloheximide, MG-132 [Z-Leu-Leu-Leu-H (aldehyde)], and ouabain were obtained from Wako Pure Chemical Industries (Osaka, Japan), Peptide Institute (Osaka, Japan), and Sigma-Aldrich, respectively. Antibodies to β-actin (AC-15; Sigma-Aldrich), c-FLIP (Dave-II; Alexis, Lausen, Switzerland), ICAM-1 (clone 15.2; Leinco Technologies, St. Louis, MO, USA), ICAM-1 (clone 28; BD Biosciences, Franklin Lakes, NJ, USA), IκBα (clone 25; BD Biosciences), p65 (20/NF-kB/p65; BD Biosciences) and horseradish-peroxidase (HRP)-linked anti-mouse and anti-rat IgG antibodies (Jackson Immunoresearch, West Grove, PA, USA) were commercially obtained.
Assay for Cell-Surface ICAM-1 Expression
A549 cells were washed twice with phosphate-buffered saline (PBS) and fixed with 1% paraformaldehyde-PBS for 15 min. After washing twice with PBS, the cells were incubated with 1% bovine serum albumin-PBS overnight. 
Assay for Cell Viability
A549 cells were pulsed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT; 500 µg/mL) for 4 h and resultant MTT formazan was solubilized with 5% sodium dodecyl sulfate overnight. Absorbance at 595 nm was measured with a Model 680 microplate reader.
Western Blotting
A549 cells, HT-1080 cells and MCF7 cells were harvested with a cell scraper, washed once with PBS, and lysed with Triton X-100 lysis buffer consisting of 50 mM Tris-HCl (pH 7.4), 1% Triton X-100, 2 mM dithiothreitol, 2 mM sodium orthovanadate, and the protease inhibitor cocktail Complete TM (Roche Diagnostics, Mannheim, Germany). Postnuclear lysate was prepared by centrifugation (10,000  g, 5 min). Protein samples (30 µg/lane) were separated by SDS-PAGE and transferred onto Hybond-ECL nitrocellulose membranes (GE Healthcare, Piscataway, NJ, USA). The membranes were incubated with primary antibodies and then HRP-conjugated secondary antibodies, followed by analysis using ECL Western blotting detection reagents (GE Healthcare).
Quantitative RT-PCR
Total RNA was extracted from A549 cells using Sepasol ® -RNA I super (Nacalai Tesque, Kyoto, Japan) and reverse-transcribed to cDNA using ReverTra Ace ® (Toyobo, Osaka, Japan) and oligo(dT) 20 according to the manufacturer's instructions. cDNA was amplified with a 7000 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) using SYBR ® Premix Ex Taq TM (Takara Bio, Otsu, Japan) and KOD -Plus-Ver. 2 DNA polymerase (Toyobo). The following primer pairs were used: ICAM-1: 5'-GGGAGGCTCCGTGCTGGTGA-3' (forward) and 5'-TCAGTGCGGCACGAGA AATTG-3' (reverse) [19] ; c-FLIP L : 5'-GCCTGTATGCCCGAGCACCG-3' (forward) and 5'-GCAGG GGGAGCCCTGAGTGA-3' (reverse) [20] ; -actin: 5'-GGCATCGTGATGGACTCCG-3' (forward) and 5'-GCTGGAAGGTGGACAGCGA-3' (reverse). PCR conditions were 94 °C for 3 min, followed by 40 cycles of 94 °C for 15 s, 58 °C for 30 s, and 68 °C for 1 min. The quantity of the initial cDNA was calculated from primer-specific standard curves. The expression level of ICAM-1 and c-FLIP L was normalized on the basis of β-actin levels.
Reporter Assay
A549 cells were transfected with a plasmid encoding κB-responsive firefly luciferase reporter gene using the Lipofectamine TM 2000 transfection reagent (Invitrogen) for 24 h. The transfected A549 cells were treated with agents as indicated. The cells were washed once with PBS, lysed with Triton X-100 lysis buffer, and centrifuged (10,000  g, 5 min). Equal amounts of cell lysates were mixed with luciferase assay solution (0.25 mM luciferin, 0.8 mM ATP, 1 mM dithiothreitol, 9 mM MgCl 2 , 25 mM Tris-phosphate (pH 7.8), 15% glycerol) and relative light units were immediately measured with a Lumitester K-100 Luminometer (Hamamatsu Photonics, Hamamatsu, Japan). 
Assay for Cell-Free Protein Synthesis
Luciferase control RNA was subjected to the cell-free reaction (30 °C, 90 min) for translation by the Rabbit Reticulocyte Lysate System (Promega, Madison, WI, USA). Reaction mixtures were mixed with the luciferase assay solution and relative light units were immediately measured with the Lumitester K-100 Luminometer.
Assay for Amino Acid Transport
A549 cells were treated with agents as indicated in control incubation buffer (125 mM NaCl, 4.8 mM KCl, 1.3 mM CaCl 2 , 1.2 mM MgSO 4 , 25 mM Hepes, 1.2 mM KH 2 PO 4 , 5.6 mM glucose, pH 7.4) and pulse-labeled with [ 3 H]L-serine (0.74 TBq/mmol; Moravek) for 5 min. This was followed by the addition of cold L-serine at the final concentration of 500 µM. The cells were immediately washed three times with ice-cold PBS and lysed with 250 mM NaOH, and this was followed by radioactivity measurement.
Assay for Na + /K + -ATPase Activity
Highly purified Na 
Statistical Analysis
Statistical significance was assessed by one-way ANOVA followed by the Tukey test for multiple comparisons. Differences of P < 0.05 were considered to be statistically significant.
Results and Discussion
Ursolic Acid Inhibits TNF-α-induced ICAM-1 Expression at Intracellular Processes Downstream of mRNA Expression
Human lung carcinoma A549 cells were alveolar epithelial cells highly responsive to pro-inflammatory cytokines and induced to express cell-surface ICAM-1, which was easily measured by the Cell ELISA assay. A549 cells were thus used as a model cell line for screening for anti-inflammatory agents as well as elucidation of their mode of actions. In our previous studies [9, 10] , ursolic acid was initially identified to inhibit the cell-surface ICAM-1 expression induced by pro-inflammatory cytokines.
A549 cells were preincubated with various concentrations of ursolic acid for 1 h and then incubated with TNF-α for 6 h in the presence of ursolic acid. Ursolic acid inhibited the TNF-α-induced expression of cell-surface ICAM-1 in a dose-dependent manner and to the background level at concentrations higher than 30 µM (Figure 2a ). This was not caused by the induction of cell death, since ursolic acid up to 50 µM did not decrease cell viability in the presence or absence of TNF-α during the same incubation time (Figure 2b ). The amount of total ICAM-1 protein as translation product was then analyzed by Western blotting. Ursolic acid inhibited the TNF--induced ICAM-1 expression profoundly at concentrations higher than 30 µM (Figure 2c ). In ursolic acid-treated samples, ICAM-1 protein bands migrated faster than those in control samples (Figure 2c) , suggesting the ursolic acid may influence post-translational modification. To further investigate the effect of ursolic acid on ICAM-1 transcription, mRNA levels were evaluated by quantitative RT-PCR. TNF-α induced a drastic induction of ICAM-1 mRNA (Figure 2d ). However, ursolic acid did not inhibit the TNF-α-induced ICAM-1 mRNA expression at concentrations up to 30 µM and decreased it partially at 40-50 µM (Figure 2d ), although ICAM-1 expression at the cell-surface level as well as the protein level was almost completely inhibited by ursolic acid (Figures 2a and 2c) . These data suggest that ursolic acid inhibits the TNF-α-induced ICAM-1 expression more effectively at processes downstream of ICAM-1 transcription.
It has been shown that TNF-α-induced ICAM-1 expression is highly NF-κB-dependent in A549 cells [25] . TNF-α stimulation induced the drastic degradation of IκBα ( Figure 3a ) and the nuclear translocation of the NF-κB subunit p65 (Figure 3b ). Ursolic acid weakly affected the TNF-α-induced IκBα degradation in A549 cells, as compared with the proteasome inhibitor MG-132 that markedly prevented the IκBα degradation (Figure 3a ). In addition, unlike MG-132, ursolic acid only marginally decreased the TNF-α-induced p65 translocation to the nucleus (Figure 3b ). In the absence of TNF-α stimulation, it seems that ursolic acid alone increases p65 nuclear translocation to some extent without inducing IκBα degradation (Figures 3a and 3b) . Consistent with a partial reduction of ICAM-1 mRNA expression by ursolic acid (Figure 2d ), these data indicate that ursolic acid does not efficiently inhibit the TNF--induced NF-κB signaling pathway. We further addressed whether the inhibitory effect of ursolic acid on TNF-α-induced ICAM-1 expression (Figure 2 ) is common to other NF-κB-responsive genes and not restricted to ICAM-1. Ursolic acid prevented the TNF-α-induced expression of c-FLIP L , a cytosolic protein mainly induced by NF-κB (Figure 4a ). By contrast, the TNF-α-induced c-FLIP L mRNA expression was not decreased but rather increased upon treatment with ursolic acid (Figure 4b ). Consistently, ursolic acid inhibited the expression of an NF-κB-responsive luciferase reporter to the background level (Figure 4c ). Taken together, our present results suggest that ursolic acid inhibits the TNF-α-induced gene expression more effectively by targeting biosynthetic processes from mRNA to protein.
To broaden the impact of our findings, the biological activity of ursolic acid was examined in two additional cell lines. Human fibrosarcoma HT-1080 cells and human breast adenocarcinoma MCF7 cells were preincubated with ursolic acid for 1 h and then incubated with TNF-α for 6 h in the presence of ursolic acid. As observed in A549 cells, ursolic acid profoundly inhibited the protein expression of ICAM-1 and c-FLIP L at concentrations more than 20 µM (Figures 5a and 5b) . 
Ursolic Acid Selectively Inhibits Cellular Protein Synthesis
To investigate the effect of ursolic acid on cellular protein synthesis, A549 cells were labeled with [ 3 H]L-amino acids and radioactivity incorporated into the acid-insoluble fractions was measured. (Figures 6c to 6e ).
The translation inhibitor cycloheximide exerted an inhibitory profile somewhat different from ursolic acid, as it prevented protein synthesis much more strongly than ursolic acid (Figures 6c) . Then, we further investigated the direct effect of ursolic acid on the cell-free translation system where luciferase mRNA was used as a template. Ursolic acid decreased the luciferase activity by 30% at 50 µM (Figure 6f ), whereas other translation inhibitors, such as puromycin, prevented luciferase activity completely (data not shown). The mechanism by which ursolic acid partially affects the cell-free translation system is currently unclear. Nevertheless, these data suggest that ursolic acid, unlike cycloheximide or puromycin, directly targets not the translation machinery but the amino acid transport across the plasma membrane. 
Ursolic Acid Selectively Inhibits Amino Acid Transport
We have recently shown that the Na (Figures 7c and 7d ). These data suggest that ursolic acid selectively inhibits the uptake of amino acids into the cells. To investigate the effect of ursolic acid on Na + -dependent amino acid transport, A549 cells were preincubated with ursolic acid for 1 h and then pulse-labeled with 
The Biological Properties of Ursolic Acid
Pro-inflammatory cytokines activate the NF-κB signaling pathway and induce the expression of a wide range of NF-κB-responsive genes, such as ICAM-1. In our screening for anti-inflammatory agents, ursolic acid was initially identified to inhibit cell-surface ICAM-1 expression induced by pro-inflammatory cytokines, such as TNF-α [9, 10] . It has been reported that ursolic acid inhibits the NF-κB signaling pathway constitutively activated or induced by pro-inflammatory cytokines or chemotherapeutic agents [11] [12] [13] [14] [15] [16] [17] [18] . However, in contrast to these previous reports, we found that ursolic acid only partially diminishes TNF-α-induced NF-κB signaling pathway but more effectively inhibits the TNF-α-induced NF-κB-responsive gene expression by targeting cellular protein synthesis at least in A549 cells. The ability of ursolic acid to inhibit the NF-κB signaling pathway may be cell-type-specific or influenced by experimental conditions such as incubation periods. In fact, relatively long pre-incubation periods (8 to 48 h) with ursolic acid (10 to 100 µM) were used to block constitutive and inducible NF-κB activation in human cancer cell lines including A549 cells [11, 12, 15, 18] .
Cardiac glycosides, such as ouabain, are known to be highly specific inhibitors of Na [26] . In accord with this notion, ursolic acid was found to inhibit the Na + -dependent membrane transport of L-serine as well as to diminish cellular protein synthesis much more strongly than DNA/RNA syntheses. Therefore, it seems most likely that ursolic acid mainly inhibits cellular protein synthesis by targeting Na + /K + -ATPase in the same mechanism as ouabain. However, as described previously [11] [12] [13] [14] [15] [16] [17] [18] , it should be noted that ursolic acid may interfere with intracellular proteins other than Na + /K + -ATPase as primary targets and modulate the NF-κB signaling pathway in different experimental settings.
Conclusions
Our present study provides a novel molecular mechanism in which ursolic acid inhibits the translation process during the TNF-α-induced NF-κB-dependent gene expression by preventing Na + /K + -ATPase. Pro-inflammatory cytokines and their activation of the NF-κB signaling pathway play a critical role in chronic inflammation, which is known to be associated with autoimmune diseases, cancer, and metabolic disorders. Ursolic acid is a constituent of popular herbs and foods. Thus, it seems plausible that ursolic acid is a beneficial natural compound that exerts anti-inflammatory activity and is effective for the prevention of chronic inflammation.
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